development & production

Commercialization of protein-based vaccines & biopharmaceuticals

Message: A Year Later

Well well here we are in December of 2010. It was a mere year ago that Dundee had a target price of $1.00 for the share value on a positive Phase 1 result. Better still is that Paradigm had a target value of $2.00 for the same positive results. As we are all aware these targets were never even close to being met and here we are a year later languishing below even the .50 cent mark. I had great hopes for this company and hopefully they have the cash to build and go forward as they have a unique platform to base some really great share values. Do they have the cash?? Will they dilute to get cash that will be needed?? Will they get bought out?? Hopefully Phase 2 will spur on a respectfull valuation.

the deputy

New Message
Please login to post a reply